Introduction to Emergency Contraceptive Pills:
The Global Emergency Contraceptive Pills Market size is expected to grow from USD 1.02 billion in 2022 to USD 1.20 billion by 2030, at a CAGR of 2.1% during the forecast period (2023-2030).
Emergency Contraceptive Pills (ECPs), sometimes referred to as the morning-after pill, are a form of contraception used to prevent pregnancy after unprotected sexual intercourse or contraceptive failure. They are not intended for regular use as a primary method of contraception. Two main types of emergency contraceptive pills: Levonorgestrel Pills these pills contain a synthetic hormone called levonorgestrel, which is a progestin. They are available over-the-counter in many countries and are most effective when taken as soon as possible after unprotected sex, ideally within 72 hours, although they can be effective up to 120 hours (5 days) after. Ulipristal Acetate (ella): This pill contains ulipristal acetate, which is a selective progesterone receptor modulator. It is available by prescription in many countries and is effective up to 120 hours (5 days) after unprotected intercourse. To avoid unwanted pregnancy, any woman or girl of reproductive age may require emergency contraception. The rising number of unintended pregnancies among women aged 15 to 44 is expected to fuel the growth of the emergency contraceptive pill market over the forecast period.
Major Key Players:
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bayer AG (Germany)
- HRA Pharma (France)
- Piramal Enterprises Limited (India)
- Mankind Pharma Ltd. (India)
- Richter Gedeon Nyrt (Hungary)
- Lupin Limited (India)
- Cooper Pharma (India)
- Pfizer Inc. (US)
- Zhejiang Xianju Pharmaceutical Co. (China)
Market Dynamics and Factors Influencing Growth:
Drivers:
Emergency contraception pills prevent unintended pregnancy by preventing delaying ovulation and do not induce abortion. The copper-containing IUD prevents fertilization by inducing a chemical reaction in the sperm and egg before they meet. Emergency contraception (EC) may be a safe and effective way to prevent an unwanted pregnancy following unprotected sexual activity. Many unwanted pregnancies end in unsafe abortions.
Restraints:
The emergency Contraceptive pill has been found to possess any long-term or serious side effects. However, some sorts of emergency contraceptive pills cause minor side effects which may be liable for hindering the market of emergency contraceptive pills. The more common side effects of ECPs include spotting for a couple of days after use and an irregular period for a subsequent month or two. Some women may have nausea and vomiting after taking ECPs
Opportunities:
The high rate of urbanization, especially in several developing nations is one of the main factors that are likely to accelerate the expansion of the worldwide market within the next few years. The rising income of consumers and therefore the rising adoption rate of emergency contraceptive pills are likely to encourage the expansion of the market throughout the forecast period. The rising awareness among people is one of the key factors that's projected to accelerate the expansion of the worldwide emergency contraceptive pills mar
Emergency Contraceptive Pills Market Segmentation:
Market Segmentation:
By Product Type
- Progesterone Pills
- Estrogen Pills
- Combination Pills
By Distribution Channel
- Online
- Offline
Product Type: The combination pill segment is forecasted to dominate the emergency contraceptive pill market in the upcoming future. The combined pill is an oral contraceptive that contains a combination of synthetic hormones. These chemicals closely resemble the naturally produced female hormones, estrogen, and progesterone, which help regulate ovulation. Combination pills see relatively higher sales in the global market, owing to their health benefits in lowering the risk of ectopic pregnancy
Distribution Channel: The offline segment is predicted to have share in the emergency contraceptive pills market. Drug stores and hospital pharmacies come under offline application of emergency contraceptive pills and are the two largest sales channels for emergency contraceptive pills. Sales of emergency contraceptive pills through these channels are expected to be more as compared to online sales of emergency contraceptive pills.
Key Industry Developments in the Emergency Contraceptive Pills Market:
- In July 2023, Teva Pharmaceuticals acquired Anda Pharmaceuticals for $575 million. This acquisition strengthens Teva's position in the women's health market, giving them access to Anda's popular EC pill, NextChoice One-Step.
- In September 2023, private equity firm Advent International acquired a significant stake in HRA Pharma, the manufacturer of Ella, an emergency contraceptive pill known for its longer window of effectiveness. This investment aims to accelerate HRA Pharma's global expansion and product development.
For this report, Introspective Market Research has segmented the Emergency Contraceptive Pills Market based on region:
Regional Outlook (Revenue in USD Million; Volume in Units, 2023-2030)
The Asia Pacific region is anticipated to have the second-highest share of the emergency contraceptive pills market over the forecast period. The Asia Pacific is developing urban culture among the developing economies and the rising awareness among people is projected to encourage the growth of the emergency contraceptive pills market across the Asia Pacific.
Europe showcases the rise in mutual consent of partners towards unprotected sex. Although unprotected coitus fuels the risks of sexually transmitted infections, emergency contraceptive pills are unable to offer protection against venereal diseases, which further negates their status in terms of adoption. The growing adoption rate of emergency contraceptive pills is fueling the growth of the emergency contraceptive pills market in the forecast period.
North America
- US
- Canada
- Mexico
Eastern Europe
- Bulgaria
- The Czech Republic
- Hungary
- Poland
- Romania
- Rest of Eastern Europe
Western Europe
- Germany
- UK
- France
- Netherlands
- Italy
- Russia
- Spain
- Rest of Western Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Thailand
- Vietnam
- The Philippines
- Australia
- New Zealand
- Rest of APAC
Middle East & Africa
- Turkey
- Bahrain
- Kuwait
- Saudi Arabia
- Qatar
- UAE
- Israel
- South Africa
South America
- Brazil
- Argentina
- Rest of SA
